Cargando…
Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?
The purpose of this study is to review the literature on the risk of malignancy in patients with inflammatory eye disease (IED) treated with systemic immunosuppressive (IS) therapy. Relevant databases in transplant medicine, autoimmune diseases and literature regarding uveitis and scleritis were rev...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695808/ https://www.ncbi.nlm.nih.gov/pubmed/23724805 http://dx.doi.org/10.1186/1869-5760-3-48 |